Rights and permissions
About this article
Cite this article
COX-2 use grows despite little added benefit over NSAIDs. Pharmacoecon. Outcomes News 471, 12 (2005). https://doi.org/10.2165/00151234-200504710-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504710-00026